H. Zhao and T. Chen, Tet family of 5-methylcytosine dioxygenases in mammalian development, J Hum Genet, vol.58, pp.421-427, 2013.

W. A. Pastor, L. Aravind, and A. Rao, TETonic shift: Biological roles of TET proteins in DNA demethylation and transcription, Nat Rev Mol Cell Biol, vol.14, pp.341-356, 2013.

M. R. Branco, G. Ficz, and W. Reik, Uncovering the role of 5-hydroxymethylcytosine in the epigenome, Nat Rev Genet, vol.13, pp.7-13, 2011.

W. Xu, H. Yang, Y. Liu, Y. Yang, and P. Wang, Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of ?-ketoglutaratedependent dioxygenases, Cancer Cell, vol.19, pp.17-30, 2011.

L. Scourzic, E. Mouly, and O. A. Bernard, TET proteins and the control of cytosine demethylation in cancer, Genome, vol.7, p.9, 2015.

T. Kraus, A. Greiner, M. Steinmaurer, V. Dietinger, and V. Guibourt, Genetic Characterization of Ten-Eleven-Translocation Methylcytosine Dioxygenase Alterations in Human Glioma, J Cancer, vol.6, pp.832-842, 2015.
DOI : 10.7150/jca.12010

URL : http://www.jcancer.org/v06p0832.pdf

K. D. Rasmussen and K. Helin, Role of TET enzymes in DNA methylation, development, and cancer, Genes Dev, vol.30, pp.733-750, 2016.
DOI : 10.1101/gad.276568.115

URL : http://genesdev.cshlp.org/content/30/7/733.full.pdf

B. Thienpont, E. Galle, and D. Lambrechts, TET enzymes as oxygendependent tumor suppressors: exciting new avenues for cancer management, Epigenomics, vol.8, pp.1445-1448, 2016.
DOI : 10.2217/epi-2016-0126

, TLX induces TET3 expression and inhibits glioblastoma stem cell selfrenewal and tumorigenesis, Nat Commun, vol.7, p.10637

R. Pacaud, Q. Sery, L. Oliver, F. M. Vallette, and J. Tost, DNMT3L interacts with transcription factors to target DNMT3L/DNMT3B to specific DNA sequences: role of the DNMT3L/DNMT3B/p65-NF?B complex in the (de-)methylation of TRAF1, Biochimie, vol.104, pp.36-49, 2014.

P. F. Cartron, A. Nadaradjane, F. Lepape, L. Lalier, and B. Gardie, Identification of TET1 Partners That Control Its DNA-Demethylating Function, Genes Cancer, vol.4, pp.235-241, 2013.

H. Takai, K. Masuda, T. Sato, Y. Sakaguchi, and T. Suzuki, 5-Hydroxymethylcytosine plays a critical role in glioblastomagenesis by recruiting the CHTOP-methylosome complex, Cell Rep, vol.9, pp.48-60, 2014.

T. Müller, M. Gessi, A. Waha, L. J. Isselstein, and D. Luxen, Nuclear exclusion of TET1 is associated with loss of 5-hydroxymethylcytosine in IDH1 wild-type gliomas, Am J Pathol, vol.181, pp.675-683, 2012.

E. B. Bian, G. Zong, Y. S. Xie, X. M. Meng, and C. Huang, TET family proteins: New players in gliomas, J Neurooncol, vol.116, pp.429-435, 2014.

Y. H. Kim, D. Pierscianek, M. Mittelbronn, A. Vital, and L. Mariani, TET2 promoter methylation in low-grade diffuse gliomas lacking IDH1/2 mutations, J Clin Pathol, vol.64, pp.850-852, 2011.

B. Chen, Y. Lei, H. Wang, Y. Dang, and P. Fang, Repression of the expression of TET2 by ZEB1 contributes to invasion and growth in glioma cells, Mol Med Rep, vol.15, pp.2625-2632, 2017.

P. Guilhamon, M. Eskandarpour, D. Halai, G. A. Wilson, and A. Feber, Meta-analysis of IDH-mutant cancers identifies EBF1 as an interaction partner for TET2, Nat Commun, vol.4, p.2166, 2013.

D. A. Goldman, K. Hovinga, A. S. Reiner, Y. Esquenazi, and V. Tabar, The relationship between repeat resection and overall survival in patients with glioblastoma: A time-dependent analysis, J Neurosurg, vol.5, pp.1-9, 2018.

S. Mallick, R. Benson, A. Hakim, and G. K. Rath, Management of glioblastoma after recurrence: A changing paradigm, J Egypt Natl Cancer Inst, vol.28, pp.199-210, 2016.

D. H. Lee, H. W. Ryu, H. R. Won, and S. H. Kwon, Advances in epigenetic glioblastoma therapy, Oncotarget, vol.8, pp.18577-18589, 2017.